Clinical Trial Update: Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction [NA]

View source ↗

Summary

A clinical trial is evaluating whether a PCSK-9 inhibitor given before primary percutaneous intervention benefits patients with ST-segment elevation myocardial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• PCSK-9 inhibitor

Snippet

Sponsor: Beijing Luhe Hospital | Conditions: STEMI | NA | Status: RECRUITING